A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Implantable Long-Acting Pre-Exposure Prophylaxis For MSM
- Status
- COMPLETED
- Phase
- N/A
The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation
- Status
- COMPLETED
- Phase
- PHASE4
Alternative Viral Load Tests During Start of Antiretroviral Therapy
- Status
- WITHDRAWN
- Phase
- NA
Pembrolizumab in Muscle-invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Elpipodect (MK-8189) in Participants With Schizophrenia (MK-8189-014)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Effectiveness of Golimumab in Patients With Ulcerative Colitis: Results of a Real-life Study in Switzerland
- Status
- COMPLETED
- Phase
- N/A
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate Molnupiravir (MK-4482; MOV) in Participants With Severe Renal Impairment (MK-4482-003)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Molnupiravir (MK-4482) in Participants With Moderate Hepatic Impairment (MK-4482-016)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers
- Status
- COMPLETED
- Phase
- PHASE2